Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|July 16, 2011
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22Weihsu C Chen, Darren S Sigal, Alan Saven, et al.Blood|July 17, 2010
Beyond hairy cell: the activity of cladribine in other hematologic malignanciesDarren S Sigal, Heather J Miller, Ethan D Schram, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2003
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cellsMelanie Rolli, Emilia Fransvea, Jan Pilch, et al.American Journal of Hematology|November 25, 2003
CD52 expression in hairy cell leukemiaMichael M Quigley, Kelly J Bethel, Robert W Sharpe, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinibDavid J Hermel, Victor Chiu, Melody H Hermel, et al.Familial Cancer|July 13, 2016
Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer ProgramDavid J Hermel, Wendy C McKinnon, Marie E Wood, et al.Cancer Causes & Control : CCC|January 20, 2007
How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?Catherine Diamond, Thomas H Taylor, Theresa Im, et al.Journal of Clinical and Translational Hepatology|May 19, 2021
Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular CarcinomaDavid J Hermel, Emma Z Du, Ray Lin, et al.Blood|February 26, 2010
In vivo targeting of B-cell lymphoma with glycan ligands of CD22Weihsu C Chen, Gladys C Completo, Darren S Sigal, et al.Clinical Breast Cancer|May 26, 2017
Multi-institutional Evaluation of Women at High Risk of Developing Breast CancerDavid J Hermel, Marie E Wood, Jennifer Chun, et al.Pageof 7